Trial reportZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2017
[Efficacy and safety of pegylated interferon α-2b injection (Y shape, 40 kD) in treatment of patients with genotype 1/6 chronic hepatitis C].
Open access · greenAbstract readClinical Trial, Phase IIIMulticenter StudyRandomized Controlled Trial
In one paragraph
Trial report in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 90% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 0 citations in OpenAlex.
- [Clinical effect and safety of pegylated interferon-α-2b injection (Y shape, 40 kD) in treatment of HBeAg-positive chronic hepatitis B patients].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2017Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
41 authors at 15 institutions in 1 country.
B FengPeking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing 100044, China.
J ShangDepartment of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou 450003, China.
S H WuDepartment of Infectious Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.
H ChenDepartment of Infectious Diseases, The First Affiliated Hospital of Lanzhou University, Lanzhou 730000, China.
Y HanDepartment of Gastroenterology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Y Q LiDepartment of Infectious Diseases, 302 Military Hospital, Beijing 100039, China.
D Z ZhangDepartment of Infectious Diseases, Institute for Viral Hepatitis, Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
L F ZhaoDepartment of Infectious Diseases, The First Affiliated Hospital of Shanxi University, Taiyuan 030001, China.
S F WeiDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
Q MaoDepartment of Infectious Disease, Southeast Hospital, Third Military Medical University, Chongqing 400038, China.
C B YinDepartment of Infectious Diseases, Guangzhou Eighth People's Hospital, Guangzhou 510060, China.
T HanDepartment of Hepatology, Tianjin Third Central Hospital, Tianjin Medical University, Tianjin 300170, China.
M R WangInstitute of Liver Disease, Nanjing 81 Hospital, Nanjing 210002, China.
S J ChenDepartment of Hepatology, Jinan Infectious Disease Hospital, Jinan 250021, China.
J LiDepartment of Infectious Diseases, Jiangsu Provincial People's Hospital, Nanjing 210029, China.
Q XieDepartment of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Z ZhenDepartment of Infectious Diseases, The Third Affiliated Hospital of Hebei Medical University, Shijiazhuang 050051, China.
Z L GaoDepartment of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510630, China.
Y X ZhangDepartment of Infectious Diseases, The First Affiliated Hospital of Xinjiang Medical University, Wulumuqi 830054, China.
G Z GongDepartment of Infectious Diseases, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
D L YangDepartment of Infectious Disease, Institute of Infectious Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
C PanDepartment of Hepatology, Fuzhou Infectious Disease Hospital, Fuzhou, 350025, China.
J F ShengThe First Affiliated Hospital of Zhengjiang University, Hangzhou 310003, China.
H TangDepartment of Infectious Diseases, Sichuan University West China Hospital, Chengdu 610041, China.
Q NingDepartment of Infectious Disease, Institute of Infectious Disease, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
G F ShiDepartment of Infectious Diseases, Huashan Hospital, Shanghai 200040, China.
J Q NiuDepartment of Infectious Diseases, The First Affiliated Hospital of Jilin University, Changchun 130062, China.
G H LuoDepartment of Infectious Diseases, The First Affiliated Hospital of Guangxi Medical Universtiy, Nanning 530021, China.
Y T SunDepartment of Infectious Diseases, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, China.
H YouLiver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
G Q WangDepartment of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.
L L ZhangDepartment of Infectious Diseases, The First Affiliated Hospital of Nanchang University, Nanchang 360102, China.
J PengDepartment of Infectious Diseases, Nangfang Hospital, Southern Medical University, Guangzhou 510510, China.
Q ZhangShanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
J J LiuDepartment of Infectious Diseases, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
C W ChenNanjing Military Command Liver Disease Research Center, Shanghai 200000, China.
X Y ChenHepatology Department, Youan Hospital, Capital Medical University, Beijing 100069, China.
W ZhaoDepartment of Hepatology, The Second Affiliated Hospital of the Southeast University, Nanjing 210003, China.
R H WangXiamen Amoytop Biotech Co., Ltd, Xiamen, 361022, China.
L SunXiamen Amoytop Biotech Co., Ltd, Xiamen, 361022, China.
L WeiPeking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing 100044, China.
Peking University · CNAir Force Medical University · CNBeijing Friendship Hospital · CNFirst Affiliated Hospital of Anhui Medical University · CNFirst Affiliated Hospital of Xiamen University · CNFirst Affiliated Hospital of Zhengzhou University · CNGuangzhou Eighth People's Hospital · CNHenan Provincial People's Hospital · CNPeking University First Hospital · CNRuijin Hospital · CNSecond Xiangya Hospital of Central South University · CNShanghai Public Health Clinical Center · CNThird Affiliated Hospital of Sun Yat-sen University · CNThird Hospital of Hebei Medical University · CNXijing Hospital · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Sustained Virologic ResponseAdultAntiviral AgentsDrug Therapy, CombinationFemaleGenotypeHepacivirusHepatitis C, ChronicHumansInterferon-alphaInterferon alpha-2MaleMiddle AgedPolyethylene GlycolsReal-Time Polymerase Chain ReactionRecombinant ProteinsAntiviral AgentsInterferon-alphaInterferon alpha-2peginterferon alfa-2apeginterferon alfa-2bPolyethylene GlycolsRecombinant ProteinsRibavirinClinical trialHepatitis C, chronicInterferons
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.